Search results
Author(s):
Niels Ramsing Holm
Added:
1 year ago
ESC 2023 — Dr Niels Ramsing Holm (Aarhus University, DK) outlines the findings from the OCTOBER trial (NCT03171311).
The OCTOBER trial (Aarhus University Hospital Skejby, Abbott) aimed to compare the median two-year clinical outcome after optical coherence tomography (OCT) guided percutaneous coronary intervention (PCI) as compared to angiographic-guided PCI. This was an investigator-initiated…
View more
Author(s):
Luca Paolucci
,
Asad Shabbir
,
Marco Lombardi
,
et al
Added:
6 months ago
IVUS Guided Bifurcation PCI with HDi IVUS
Video Series
Approaches to Bifurcation Management
Video Series
Author(s):
Andrew Vanezis
Added:
1 year ago
Author(s):
David Erlinge
Added:
8 months ago
TCT Conference 2024 - Significant reduction in TLF and TVF and flattening of event curves after 6 months in favour of DynamX Bioadaptor.Dr David Erlinge (Skane University Hospital, Lund, SE) joins us onsite at TCT Conference to discuss the findings from INFINITY-SWEDEHEART (NCT04562805).INFINITY-SWEDEHEART is a prospective, multicenter, randomized registry-based clinical trial, where patients…
View more
ESC 24: The OCCUPI Trial
Author(s):
Byeong-Keuk Kim
Added:
10 months ago
Video
Author(s):
Max W Maffey
,
Rodrigo Bagur
Added:
11 months ago
Author(s):
Nitin Chandramohan
,
Jonathan Hinton
,
Peter O’Kane
,
et al
Added:
1 year ago
Author(s):
Ankur Kalra
,
Sukhjinder Nijjer
Added:
1 year ago
In this week's Parallax, Dr Ankur Kalra welcomes back Dr Sukhjinder Nijjer for their much-anticipated annual review of advancements in cardiovascular medicine that defined the year 2023.Dr Nijjer, a Consultant Cardiologist in the UK, serves as the President of the Royal Society of Medicine and is an Honorary Senior Clinical Lecturer at Imperial College London.Drs Kalra and Nijjer share their…
View more